Clinical Trials · NCT01120236
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- National Cancer Institute (NCI)
- Enrollment
- 211
- Start date
- Dec 2010
- Locations
- 170 sites, United States, Canada
- Primary endpoint
- Undetectable PSA Rate